Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aztreonam.

P Clark1

  • 1Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville.

Obstetrics and Gynecology Clinics of North America
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Aztreonam is a synthetic monobactam antibiotic effective against aerobic gram-negative bacteria. It treats resistant urinary tract infections and can be combined with clindamycin for pelvic infections.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atypical femoral fractures in a Mexican cohort of children and adolescents with osteogenesis imperfecta. Analysis of trajectories.

Acta ortopedica mexicana·2026
Same author

Latin American patients' perceptions on osteoporosis diagnosis and treatment: The IOF Patient Advisory Group in Latin America.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2025
Same author

Joint position on quality indicators for fragility hip fracture in Mexico.

Archives of osteoporosis·2025
Same author

Optimisation of vitamin D status in global populations.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2024
Same author

Subclinical to catastrophic: a range of outcomes in cerebral air embolism.

Emergency radiology·2023
Same author

Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group.

Archives of osteoporosis·2022
Same journal

Bridging Science and Practice in Gender-Affirming Care: A Compendium for Gynecologists.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evidence, Clinical Expertise, and Research Gaps in Gender-Affirming Care.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evaluation and Management of the Pediatric Gender-Diverse Patient.

Obstetrics and gynecology clinics of North America·2026
Same journal

Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.

Obstetrics and gynecology clinics of North America·2026
Same journal

Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women.

Obstetrics and gynecology clinics of North America·2026
Same journal

Contraceptive Needs of the Transmasculine Patient.

Obstetrics and gynecology clinics of North America·2026
See all related articles

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Antibiotic Research

Background:

  • Aztreonam is a synthetic monobactam antibiotic.
  • It exhibits potent activity against aerobic gram-negative bacilli.

Purpose of the Study:

  • To highlight the therapeutic applications of aztreonam.
  • To discuss its use in treating resistant infections.

Main Methods:

  • Review of aztreonam's pharmacological properties.
  • Clinical application analysis for urinary tract and pelvic infections.

Main Results:

  • Aztreonam demonstrates excellent efficacy against aerobic gram-negative pathogens.
  • It serves as a viable monotherapy for resistant upper urinary tract infections.
  • Combination therapy with clindamycin is effective for pelvic inflammatory and postoperative infections.

    • Conclusions:

    • Aztreonam is a valuable antibiotic for specific gram-negative infections.
    • Its use is indicated in cases of resistance to other common antibiotics.
    • It offers treatment options for complex pelvic infections.